Endoscopic injection of adrenaline for benign oesophageal ulcer haemorrhage

1994 ◽  
Vol 81 (9) ◽  
pp. 1317-1318
Author(s):  
K. G. M. Park ◽  
R. J. C. Steele ◽  
J. Masson
Keyword(s):  
Endoscopic Injection ◽  
Oesophageal Ulcer ◽  
Ulcer Haemorrhage

Endoscopic injection of adrenaline for severe peptic ulcer haemorrhage in high surgical risk patients

1991 ◽  
Vol 17 (5) ◽  
pp. 281-284 ◽  
Author(s):  
C. Duhamel ◽  
B. Parent ◽  
C. Peillon ◽  
C. Guédon ◽  
P. Ducrotte ◽  
...  
Keyword(s):  
Peptic Ulcer ◽  
Endoscopic Injection ◽  
Surgical Risk ◽  
High Surgical Risk ◽  
Ulcer Haemorrhage ◽  
Risk Patients ◽  
Peptic Ulcer Haemorrhage

scholarly journals Radiation exposure dose of fluoroscopy-guided gastrointestinal procedures: A single-center retrospective study

2020 ◽  
Vol 08 (12) ◽  
pp. E1872-E1877
Author(s):  
Shiro Hayashi ◽  
Tsutomu Nishida ◽  
Shinji Kuriki ◽  
Li-sa Chang ◽  
Kazuki Aochi ◽  
...  
Keyword(s):  
Radiation Exposure ◽  
Balloon Dilatation ◽  
Exposure Dose ◽  
Sigmoid Volvulus ◽  
Tube Placement ◽  
Injection Sclerotherapy ◽  
Single Center ◽  
Endoscopic Injection ◽  
Dose Area Product ◽  
Esophageal Balloon

Abstract Background and study aims Fluoroscopy-guided gastrointestinal procedures (FGPs) are increasingly common. However, the radiation exposure (RE) to patients undergoing FGPs is still unclear. We examined the actual RE of FGPs. Patients and methods This retrospective, single-center cohort study included consecutive FGPs, including endoscopic retrograde cholangiopancreatography (ERCP), interventional endoscopic ultrasound (EUS), enteral stenting, balloon-assisted enteroscopy, tube placement, endoscopic injection sclerotherapy (EIS), esophageal balloon dilatation and repositioning for sigmoid volvulus, from September 2012 to June 2019. We measured the air kerma (AK, mGy), dose area product (DAP, Gycm2), and fluoroscopy time (FT, min) for each procedure. Results In total, 3831 patients were enrolled. Overall, 2778 ERCPs were performed. The median AK, DAP, and FT were as follows: ERCP: 109 mGy, 13.3 Gycm2 and 10.0 min; self-expandable enteral stenting (SEMS): 62 mGy, 12.4 Gycm2 and 10.4 min; tube placement: 40 mGy, 13.8 Gycm2 and 11.1 min; balloon-assisted enteroscopy: 43 mGy, 22.4 Gycm2 and 18.2 min; EUS cyst drainage (EUS-CD): 96 mGy, 18.3 Gycm2 and 10.4 min; EIS: 36 mGy, 8.1 Gycm2 and 4.4 min; esophageal balloon dilatation: 9 mGy, 2.2 Gycm2 and 1.8 min; and repositioning for sigmoid volvulus: 7 mGy, 4.7 Gycm2 and 1.6 min. Conclusion This large series reporting actual RE doses of various FGPs could serve as a reference for future prospective studies.

Manometrically-guided endoscopic injection of botulinum toxin for esophageal achalasia: A pilot trial

2000 ◽  
Vol 38 (11) ◽  
pp. 899-903 ◽  
Author(s):  
T Wehrmann ◽  
Th Schmitt ◽  
C F Dietrich ◽  
W F Caspary ◽  
H Seifert
Keyword(s):  
Botulinum Toxin ◽  
Pilot Trial ◽  
Esophageal Achalasia ◽  
Endoscopic Injection

ENDOSCOPIC INJECTION OF GLUTARALDEHYDE CROSS-LINKED COLLAGEN FOR EFFERENT LIMB INCOMPETENCE IN THE INDIANA RESERVOIR

1998 ◽  
Vol 159 (3) ◽  
pp. 804-805 ◽  
Author(s):  
JOHN J. SMITH ◽  
STANLEY J. SWIERZEWSKI ◽  
WILLIAM BIHRLE ◽  
MICHAEL J. MALONE ◽  
JOHN A. LIBERTINO
Keyword(s):  
Endoscopic Injection ◽  
Efferent Limb

scholarly journals Endoscopic Injection Therapy in Bleeding Peptic Ulcers. Low Mortality in a High Risk Population

1992 ◽  
Vol 6 (5) ◽  
pp. 265-268 ◽  
Author(s):  
Joaqulm Balanzó ◽  
Candid Villanueva ◽  
Jorge C Espinós ◽  
Sergio Sáinz ◽  
German Soriano ◽  
...  
Keyword(s):  
High Risk ◽  
Injection Therapy ◽  
High Risk Population ◽  
Peptic Ulcers ◽  
Endoscopic Injection ◽  
Simple Method ◽  
Arterial Bleeding ◽  
Bleeding Peptic Ulcers ◽  
Initial Control ◽  
Bleeding Ulcers

Endoscoric injection therapy was performed in 341 patients consecutively admitted with a bleeding peptic ulcer at high risk of further hemorrhage, assessed by the presence of active arterial bleeding or a nonbleeding visible vessel at emergency endoscopy. Initial hemostasis was achieved in 111 of 119 actively bleeding patients (93%). Rebleeding ocurred in 75 cases (23%), at a mean interval of 53±52 h. A second emergency injection was a ttempted in 36 therapeutic failures, and was successful in 20 (55%). Emergency surgery was finally required in 52 patients (15%). Overall mortality was 4.9%. Major complications occurred in four patients (1.2%) (two perforations and two aspiration pneumonia); therefore, injection therapy is an effective and simple method for treating bleeding ulcers, achieving the initial control of hemorrhage in a majority of cases although the rate of further hemorrhage is not negligible and complications are not irrelevant.

Sign in / Sign up

Export Citation Format

Share Document